Biohaven Pharma (BHVN) Misses Q1 EPS by 47c

Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($2.17), $0.47 worse than the analyst estimate of ($1.70).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Backblaze (BLZE) call put ratio 12.9 calls to 1 put with a focus on July 12.50 calls as share price up 40%
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI